Recruiting
Breast cancer+3
RecruitingA Study Comparing GDC-4198 Alone and with Giredestrant versus Abemaciclib with Giredestrant for Advanced Breast Cancer After Previous CDK4/6 Treatment
Registered drugNo placebo
A Study Comparing GDC-4198 Alone and with Giredestrant versus Abemaciclib with Giredestrant for Advanced Breast Cancer After Previous CDK4/6 Treatment
Registered drugNo placebo
- Disease:Breast cancerBreast cancer metastatic+2
- Substances:AbemaciclibGiredestrant+1
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Abemaciclib



